Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.54 |
| ▸ | ERN1 | O75460 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.41 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | BLVRB | P30043 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29396210 | 0.98 | TTR (0.56) | TTRERN1MAOBTP53AKR1C4 | |
| SCHEMBL425350 | 0.98 | TTR (0.56) | TTRERN1MAOBTP53AKR1C4 | |
| Lithium SCHEMBL410866 | 0.96 | TTR (0.54) | TTRERN1MAOBTP53AKR1C4 | |
| SCHEMBL9398438 | 0.96 | TTR (0.54) | TTRERN1MAOBTP53AKR1C4 | |
| SCHEMBL27960207 | 0.96 | TTR (0.54) | TTRERN1MAOBTP53AKR1C4 | |
| SCHEMBL23803707 | 0.96 | TTR (0.54) | TTRERN1MAOBTP53AKR1C4 | |
| Lithium SCHEMBL30311136 | 0.96 | TTR (0.54) | TTRERN1MAOBTP53AKR1C4 | |
| SCHEMBL9403722 | 0.96 | TTR (0.54) | TTRERN1MAOBTP53AKR1C4 | |
| SCHEMBL27658640 | 0.96 | TTR (0.54) | TTRERN1MAOBTP53AKR1C4 | |
| Water SCHEMBL9398918 | 0.94 | TTR (0.52) | TTRERN1MAOBTP53AKR1C4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117822128-A | Single-cell whole genome library and combined indexing method for preparing same | 俄勒冈健康与科学大学 | 2024-04-05 | — | — | CN | claimed |
| CN-101918212-B | There is the transparent multilayer sheet of electrostatic dissipative properties | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2016-04-27 | — | — | CN | claimed |
| US-8808843-B2 | Transparent multilayer sheet having electrostatic dissipative properties | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2014-08-19 | — | — | US | claimed |
| US-20120021198-A1 | Transparent Multilayer Sheet Having Electrostatic Dissipative Properties | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2012-01-26 | — | — | US | claimed |
| CN-101918212-A | Transparent multilayer sheet having electrostatic dissipative properties | LUBRIZOL ADVANCED MAT INC | 2010-12-15 | — | — | CN | claimed |
| EP-2227391-A1 | TRANSPARENT MULTILAYER SHEET HAVING ELECTROSTATIC DISSIPATIVE PROPERTIES | Lubrizol Advanced Materials, Inc. (US) | 2010-09-15 | — | — | EP | claimed |
| WO-2009086246-A1 | TRANSPARENT MULTILAYER SHEET HAVING ELECTROSTATIC DISSIPATIVE PROPERTIES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2009-07-09 | — | — | WO | claimed |
| WO-2008018776-A1 | ELECTROSTATIC DISSIPATIVE POLYMER AND POLYMER MIXTURE THEREOF | SK CHEMICALS CO., LTD. (KR) | 2008-02-14 | — | — | WO | claimed |
| WO-1993003375-A1 | AUTOANTIBODIES AND THEIR TARGETS IN THE DIAGNOSIS OF PERIPHERAL NEUROPATHIES | WASHINGTON UNIVERSITY (US) | 1993-02-18 | — | — | WO | claimed |
| US-12576055-B2 | Disease detection and treatment based on trimethyl-lysine levels | THE CLEVELAND CLINIC FOUNDATION (US) | 2026-03-17 | — | — | US | disclosed |
| US-20250283819-A1 | RAPID PATHOLOGY/CYTOLOGY WITHOUT WASH | ESSENLIX CORPORATION (US) | 2025-09-11 | — | — | US | disclosed |
| US-12405216-B2 | Rapid pathology/cytology without wash | ESSENLIX CORPORATION (US) | 2025-09-02 | — | — | US | disclosed |
| US-20250249453-A1 | SYSTEMS AND METHODS FOR SERIAL FLOW EMULSION PROCESSES | DROPWORKS, INC. | 2025-08-07 | — | — | US | disclosed |
| US-12364981-B2 | Systems and methods for serial flow emulsion processes | DROPWORKS, INC. (US) | 2025-07-22 | — | — | US | disclosed |
| EP-0437800-A1 | Derivatives and analogues of monoethylglycinexylidide and their production and use | ABBOTT LABORATORIES (US) | 1991-07-24 | — | — | EP | disclosed |
| US-4859464-A | SOLUBILIZATION WITH NONIONIC DETERGENT | ANTONIO LAWRENCE E (US) | 1989-08-22 | — | — | US | disclosed |
| EP-0101505-B1 | METHOD FOR THE PURIFICATION OF PARASITE ANTIGENIC FACTORS | D'ANTONIO, Lawrence E. (US) | 1987-11-04 | — | — | EP | disclosed |
| EP-0101505-A4 | METHOD FOR THE PURIFICATION OF PARASITE ANTIGENIC FACTORS. | D ANTONIO LAWRENCE E | 1984-07-06 | — | — | EP | disclosed |
| EP-0101505-A1 | METHOD FOR THE PURIFICATION OF PARASITE ANTIGENIC FACTORS. | ANTONIO LAWRENCE E | 1984-02-29 | — | — | EP | disclosed |
| WO-1983002896-A1 | METHOD FOR THE PURIFICATION OF PARASITE ANTIGENIC FACTORS | D'ANTONIO, LAWRENCE, E. | 1983-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576055-B2 | Disease detection and treatment based on trimethyl-lysine levels | BHMT, BHMT2, EHMT2 | TTR 386/4885ERN1 2851/4885MAOB 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.